Etanercept therapy allows the tapering of methotrexate and sustained clinical responses in patients with moderate to severe psoriasis.
about
Systemic methotrexate therapy for psoriasis: past, present and future.Use of biologic agents in combination with other therapies for the treatment of psoriasisEtanercept, improved dosage schedules and combinations in the treatment of psoriasis: an update.A dermatologist guide to immunogenicityLow-dose methotrexate - a therapeutical kick in TNF-alpha antagonist treatment for recalcitrant psoriasis vulgaris.Exacerbation of psoriasis under efalizumab therapy.
P2860
Etanercept therapy allows the tapering of methotrexate and sustained clinical responses in patients with moderate to severe psoriasis.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh
2008年學術文章
@zh-hant
name
Etanercept therapy allows the ...... moderate to severe psoriasis.
@en
Etanercept therapy allows the ...... moderate to severe psoriasis.
@nl
type
label
Etanercept therapy allows the ...... moderate to severe psoriasis.
@en
Etanercept therapy allows the ...... moderate to severe psoriasis.
@nl
prefLabel
Etanercept therapy allows the ...... moderate to severe psoriasis.
@en
Etanercept therapy allows the ...... moderate to severe psoriasis.
@nl
P1476
Etanercept therapy allows the ...... moderate to severe psoriasis.
@en
P2093
Nicholas J Lowe
Paul S Yamauchi
P304
P356
10.1111/J.1365-4632.2008.03419.X
P577
2008-02-01T00:00:00Z